1. Wolf, PA, Abbott, RD, Kannel, WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991;22(8):983-8.
2. Macle, L, Cairns, J, Leblanc, K, et al. 2016. focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation. Can J Cardiol 2016;32(10):1170-85.
3. Miller, PS, Andersson, FL, Kalra, L. Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated? Stroke 2005;36(2):360-6.
4. Giugliano, RP, Ruff, CT, Braunwald, E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013;369(22):2093-2104.
5. Patel, MR, Mahaffey, KW, Garg, J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365(10):883-891.
6. Connolly, SJ, Ezekowitz, MD, Yusuf, S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361(12):1139-51.
7. Granger, CB, Alexander, JH, McMurray, JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365(11):981-992.
8. Atzema, CL, Austin, PC, Miller, E, et al. A population-based description of atrial fibrillation in the emergency department, 2002 to 2010. Ann Emerg Med 2013;62(6):570-577e7.
9. Sandhu, RK, Bakal, JA, Ezekowitz, JA, McAlister, FA. The epidemiology of atrial fibrillation in adults depends on locale of diagnosis. Am Heart J 2011;161(5):986-992e1.
10. Miyasaka, Y, Barnes, ME, Gersh, BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114(2):119-125.
11. Atzema, CL, Austin, PC, Chong, AS, et al. The long-term use of warfarin among atrial fibrillation patients discharged from an emergency department with a warfarin prescription. Ann Emerg Med 2015;66(4):347-354e2.
12. Coll-Vinent, B, Martin, A, Malagon, F, et al. Stroke prophylaxis in atrial fibrillation: searching for management improvement opportunities in the emergency department: the HERMES-AF study. Ann Emerg Med 2015;65(1):1-12.
13. Scheuermeyer, FX, Innes, G, Pourvali, R, et al. Missed opportunities for appropriate anticoagulation among emergency department patients with uncomplicated atrial fibrillation or flutter. Ann Emerg Med 2013;62(6):557-565e2.
14. Scott-Herridge, JA, Seifer, CM, Steigerwald, R, et al. A multi-hospital analysis of predictors of oral anticoagulation prescriptions for patients with actionable atrial fibrillation who attend the emergency department. Acute Card Care 2017;3:1-8.
15. Southern, DA, Norris, CM, Quan, H, et al. An administrative data merging solution for dealing with missing data in a clinical registry: adaptation from ICD-9 to ICD-10. BMC Med Res Methodol 2008;8:1.
16. Di Biase, L. Use of direct oral anticoagulants in patients with atrial fibrillation and valvular heart lesions. J Am Heart Assoc 2016;5(2).
17. Verma, A, Cairns, JA, Mitchell, LB, et al. 2014. focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation. Can J Cardiol 2014;30(10):1114-30.
18. Atzema, CL. Stroke prevention for high-risk atrial fibrillation in the emergency setting: the emergency physician perspective. Can J Cardiol 2018;34(2):125-131.
19. Barrett, TW, Vermeulen, MJ, Self, WH, et al. Emergency department management of atrial fibrillation in the United States versus Ontario, Canada. J Am Coll Cardiol 2015;65(20):2258-60.
20. Barrett, TW, Marill, KA. Anticoagulation for emergency department patients with atrial fibrillation: is our duty to inform or prescribe? Ann Emerg Med 2013;62(6):566-8.
21. Skolarus, LE, Morgenstern, LB, Scott, PA, et al. An emergency department intervention to increase warfarin use for atrial fibrillation. J Stroke Cerebrovasc Dis 2014;23(2):199-203.
22. Grudniewicz, A, Kealy, R, Rodseth, RN, et al. What is the effectiveness of printed educational materials on primary care physician knowledge, behaviour, and patient outcomes: a systematic review and meta-analyses. Implement Sci 2015;10:164.
23. Coll-Vinent, B, Pacheco, G, Junyent, M, et al. Impact of implementing common guidelines at different care levels in a healthcare area on the improvement of atrial fibrillation treatment. Rev Esp Cardiol 2007;60(4):392-403.
24. Chin, HL, Wallace, P. Embedding guidelines into direct physician order entry: simple methods, powerful results. Proc AMIA Symp 1999;1: 221-5.
25. Milani, RV, Lavie, CJ, Dornelles, AC. The impact of achieving perfect care in acute coronary syndrome: the role of computer assisted decision support. Am Heart J 2012;164(1):29-34.
26. Robson, J, Dostal, I, Mathur, R, et al. Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts. Br J Gen Pract 2014;64(622):e275-81.
27. Silbernagel, G, Spirk, D, Hager, A, et al. Electronic alert system for improving stroke prevention among hospitalized oral-anticoagulation-naive patients with atrial fibrillation: a randomized trial. J Am Heart Assoc 2016;5:e003776.
28. Sandhu, RK, Bakal, JA, Ezekowitz, JA, McAlister, FA. Risk stratification schemes, anticoagulation use and outcomes: the risk-treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation. Heart 2011;97(24):2046-50.
29. Tan, AY, Ellenbogen, KA. Comparing the imperfect with the imperfect: the imprecise science of assessing the risk and benefits of anticoagulation in atrial fibrillation. Circulation 2014;129(20):1997-9.